Uploaded August 2026 | Updated November 2026, 2 hours ago
At 13, Evan runs his own bike YouTube channel, manages type 1 and celiac himself with a 6.6 A1c, and just did three weeks in Spain solo. He named this episode.
ABLEnow save for today’s needs or invest for tomorrow
Eversense CGM
Medtronic Diabetes
Tandem Mobi **
Use code JUICEBOX to save 20% at Cozy Earth
CONTOUR NextGen smart meter and CONTOUR DIABETES app
Dexcom G7
Go tubeless with Omnipod 5 or Omnipod DASH *
Get your supplies from US MED or call 888-721-1514
Touched By Type 1
Take the T1DExchange survey
Apple Podcasts> Subscribe to the podcast today!
The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices
The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you!
*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.
** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo
Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.
If the podcast has helped you to live better with type 1 please tell someone else how to find it!
At 13, Evan runs his own bike YouTube channel, manages type 1 and celiac himself with a 6.6 A1c, and just did three weeks in Spain solo. He named this episode.
ABLEnow save for today’s needs or invest for tomorrow
Eversense CGM
Medtronic Diabetes
Tandem Mobi **
Use code JUICEBOX to save 20% at Cozy Earth
CONTOUR NextGen smart meter and CONTOUR DIABETES app
Dexcom G7
Go tubeless with Omnipod 5 or Omnipod DASH *
Get your supplies from US MED or call 888-721-1514
Touched By Type 1
Take the T1DExchange survey
Apple Podcasts> Subscribe to the podcast today!
The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices
The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you!
*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.
** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo
Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.
If the podcast has helped you to live better with type 1 please tell someone else how to find it!





![Retatrutide vs Tirzepatide vs Semaglutide: Which Works Best? What the Trials Show
Retatrutide vs tirzepatide vs semaglutide: which one works best for weight loss, and what else do they do? This video compares retatrutide (not yet approved), tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) using the trial results.
In this video:
- How much weight people lost on each one, and the head-to-head trials
- How they work: GLP-1, GIP and glucagon
- Insulin resistance, the heart, the liver and inflammation
- What is known for type 1 diabetes
- Side effects, muscle loss, and what happens when you stop
- Why retatrutide sold online is not the drug from the trials
0:00 Three shots that came out of diabetes research
0:11 Semaglutide, tirzepatide and retatrutide
0:33 How much weight people lost
1:01 The head-to-head trials
1:25 How GLP-1 works
1:58 One switch, two switches, three switches
2:36 Insulin resistance
3:48 Semaglutide: heart, liver, Alzheimers
4:21 Tirzepatide: sleep apnea, heart failure, psoriasis
4:59 Retatrutide: liver fat, knee pain, sleep apnea
5:24 Inflammation
5:52 Autoimmune and other studies
6:23 Type 1 diabetes
7:01 Side effects
7:46 What happens when people stop
8:04 Retatrutide is not approved
8:21 The short version
What is a peptide? The three-part series: [PEPTIDE PLAYLIST LINK]
Full episodes free, wherever you get audio: https://www.juiceboxpodcast.com
Apple Podcasts: http://bit.ly/JBPAPod
Spotify: http://bit.ly/JBPspot
Retatrutide is investigational. It is not approved by the FDA and cannot legally be prescribed or compounded.
Sources:
Weight loss: STEP-1 (Wilding, NEJM 2021); STEP UP and the Wegovy HD approval, March 2026; SURMOUNT-1 (Jastreboff, NEJM 2022); TRIUMPH-1 (Jastreboff, NEJM 2026); SURMOUNT-5 (Aronne, NEJM 2025).
Insulin resistance: SURMOUNT-1 three-year prediabetes analysis (NEJM 2024); Heise, Lancet Diabetes Endocrinol 2022.
Semaglutide: SELECT (Lincoff, NEJM 2023); evoke and evoke+ (Lancet 2026).
Tirzepatide: SUMMIT; TOGETHER-PsO (Lilly, 2026).
Retatrutide: Sanyal, Nat Med 2024; TRIUMPH-1.
Autoimmune: Karacabeyli, Arthritis Rheumatol 2026.
Type 1: Diabetes Care 2026;49(1):161; Johns Hopkins records study, March 2026.
Safety and stopping: STEP-1 extension; SURMOUNT-1 body composition substudy; MHRA, February 2026.
Nothing you hear on the Juicebox Podcast should be considered advice, medical or otherwise. Always consult a physician before making any changes to your healthcare plan.
Made November 2026.
#retatrutide #tirzepatide #semaglutide Retatrutide vs Tirzepatide vs Semaglutide: Which Works Best? What the Trials Show](https://i.ytimg.com/vi/oYOi3Ge486I/mqdefault.jpg)




